SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-097142
Filing Date
2016-04-28
Accepted
2016-04-28 16:36:15
Documents
3
Period of Report
2016-06-29
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A v438151_def14a.htm DEF 14A 425579
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-16-097142.txt   427200
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: DEF 14A | Act: 34 | File No.: 001-36288 | Film No.: 161600622
SIC: 2834 Pharmaceutical Preparations